Discover why Recursion Pharmaceuticals, Inc. stands out in AI drug discovery, but faces valuation risks. Click for my look at ...

In a surprising turn of scientific discovery, a longstanding blood pressure medication may offer new hope in the fight against fast-growing cancers. Recent laboratory research has revealed that ...

Two complementary studies led by researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS ...

Rakovina Therapeutics Inc. ('Rakovina” or the 'Company”) (TSX-V: RKV)(FSE: 7JO0) a biopharmaceutical company advancing cancer therapies through AI-enabled drug discovery, today announced that its ...

Scientists accidentally discovered that a common blood pressure drug called hydralazine could actually slow down fast-growing cancer. The cancer cell in this study is specifically glioblastoma, a form ...

A Western-led interdisciplinary research team is using artificial intelligence (AI) to target a potentially harmful enzyme found in the human body ...

Scientists accidentally discovered how an old blood pressure drug hydralazine could fight aggressive brain cancer by ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week.

For rare diseases, AI-driven repurposing fills a critical gap. With more than 7000 rare diseases and only a small percentage ...

One person's side effect could be another person's treatment if we expand our perspective on small molecule drug targets, according to a new study published November 5, 2025, in npj Precision Oncology ...